Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Dyslipidemia

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 113 articles:
HTML format



Single Articles


    January 2022
  1. SUZUKI K, Suda G, Yamamoto Y, Abiko S, et al
    Effect of switching from tenofovir disoproxil fumarate to tenofovir alafenamide on lipid profiles in patients with hepatitis B.
    PLoS One. 2022;17:e0261760.
    PubMed     Abstract available


  2. TIAN G, Wu Y, Jin X, Zeng Z, et al
    The incidence rate and influence factors of hemolysis, lipemia, icterus in fasting serum biochemistry specimens.
    PLoS One. 2022;17:e0262748.
    PubMed     Abstract available


  3. MATSUNAGA T, Kadomatsu Y, Tsukamoto M, Kubo Y, et al
    Associations of breastfeeding history with metabolic syndrome and cardiovascular risk factors in community-dwelling parous women: The Japan Multi-Institutional Collaborative Cohort Study.
    PLoS One. 2022;17:e0262252.
    PubMed     Abstract available


  4. TABATABAEI-MALAZY O, Saeedi Moghaddam S, Masinaei M, Rezaei N, et al
    Association between being metabolically healthy/unhealthy and metabolic syndrome in Iranian adults.
    PLoS One. 2022;17:e0262246.
    PubMed     Abstract available


  5. ABURUZ S, Al-Azayzih A, ZainAlAbdin S, Beiram R, et al
    Clinical characteristics and risk factors for mortality among COVID-19 hospitalized patients in UAE: Does ethnic origin have an impact.
    PLoS One. 2022;17:e0264547.
    PubMed     Abstract available


  6. HAMMAD EA, Al-Aqeel S, Elayah E, Jaber D, et al
    Assessing content and factors influencing responses to information requests in community pharmacies in Jordan: A simulated patients study.
    PLoS One. 2022;17:e0264224.
    PubMed     Abstract available


  7. BHATTARAI S, Bista B, Yadav BK, Gynawali P, et al
    Estimation of mean population salt intakes using spot urine samples and associations with body mass index, hypertension, raised blood sugar and hypercholesterolemia: Findings from STEPS Survey 2019, Nepal.
    PLoS One. 2022;17:e0266662.
    PubMed     Abstract available


  8. ANENI EC, Saeed GJ, Bittencourt MS, Cainzos-Achirica M, et al
    Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals.
    PLoS One. 2022;17:e0266505.
    PubMed     Abstract available


  9. BRANAS F, Galindo MJ, Torralba M, Antela A, et al
    Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817).
    PLoS One. 2022;17:e0266191.
    PubMed     Abstract available


  10. MARTINEZ CA, Rikhi R, Pester MS, Parker M, et al
    Abacavir antiretroviral therapy and indices of subclinical vascular disease in persons with HIV.
    PLoS One. 2022;17:e0264445.
    PubMed     Abstract available


  11. AH YM, Jeong M, Choi HD
    Comparative safety and efficacy of low- or moderate-intensity statin plus ezetimibe combination therapy and high-intensity statin monotherapy: A meta-analysis of randomized controlled studies.
    PLoS One. 2022;17:e0264437.
    PubMed     Abstract available


  12. WALDMANN E, Wu L, Busygina K, Altenhofer J, et al
    Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia).
    PLoS One. 2022;17:e0265838.
    PubMed     Abstract available


  13. WANG SK, Lee MC, Hung CL, Chen HH, et al
    Association between hypertriglyceridemic waist phenotype and hypogonadism in Taiwanese adult men.
    PLoS One. 2022;17:e0265629.
    PubMed     Abstract available


  14. HAMADA S, Takata T, Yamada K, Yamamoto M, et al
    Steatosis is involved in the progression of kidney disease in a high-fat-diet-induced non-alcoholic steatohepatitis mouse model.
    PLoS One. 2022;17:e0265461.
    PubMed     Abstract available


  15. ERTURK ZARARSIZ G, Bolat S, Cephe A, Kochan N, et al
    Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations.
    PLoS One. 2022;17:e0263860.
    PubMed     Abstract available


  16. MCDONALD R, Kuhn K, Nguyen TB, Tannous A, et al
    A randomized clinical trial demonstrating cell type specific effects of hyperlipidemia and hyperinsulinemia on pituitary function.
    PLoS One. 2022;17:e0268323.
    PubMed     Abstract available


  17. PARK YS, Ryu GW, Choi M
    Multiple metabolic comorbidities and their consequences among patients with peripheral arterial disease.
    PLoS One. 2022;17:e0268201.
    PubMed     Abstract available


  18. AL-ASHWAL FY, Sulaiman SAS, Sheikh Ghadzi SM, Kubas MA, et al
    Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen.
    PLoS One. 2022;17:e0269002.
    PubMed     Abstract available


  19. EFREMOV Y, Ermolaeva A, Vladimirov G, Gordleeva S, et al
    A mathematical model of in vitro hepatocellular cholesterol and lipoprotein metabolism for hyperlipidemia therapy.
    PLoS One. 2022;17:e0264903.
    PubMed     Abstract available


  20. DE OLIVEIRA CM, Pavani JL, Liu C, Balcells M, et al
    Comparing different metabolic indexes to predict type 2 diabetes mellitus in a five years follow-up cohort: The Baependi Heart Study.
    PLoS One. 2022;17:e0267723.
    PubMed     Abstract available


  21. ALOWAYESH MS, Aljunid SM, Al-Adsani A, Alessa T, et al
    Utilization and cost of drugs for diabetes and its comorbidities and complications in Kuwait.
    PLoS One. 2022;17:e0268495.
    PubMed     Abstract available


  22. SHARMA S, Khudiwal A, Bhardwaj S, Chaturvedi H, et al
    Healthcare worker-based opportunistic screening for familial hypercholesterolemia in a low-resource setting.
    PLoS One. 2022;17:e0269605.
    PubMed     Abstract available


  23. ALBUQUERQUE J, Medeiros AM, Alves AC, Bourbon M, et al
    Comparative study on the performance of different classification algorithms, combined with pre- and post-processing techniques to handle imbalanced data, in the diagnosis of adult patients with familial hypercholesterolemia.
    PLoS One. 2022;17:e0269713.
    PubMed     Abstract available


  24. SAGACETA-MEJIA J, Tolentino-Mayo L, Cruz-Casarrubias C, Nieto C, et al
    Understanding of front of package nutrition labels: Guideline daily amount and warning labels in Mexicans with non-communicable diseases.
    PLoS One. 2022;17:e0269892.
    PubMed     Abstract available


  25. ACHILA OO, Abrhaley F, Kesete Y, Tesfaldet F, et al
    Dyslipidemia and associated risk factors among HIV/AIDS patients on HAART in Asmara, Eritrea.
    PLoS One. 2022;17:e0270838.
    PubMed     Abstract available


  26. CHHABRA M, Vidyasagar K, Gudi SK, Sharma J, et al
    Efficacy and safety of saroglitazar for the management of dyslipidemia: A systematic review and meta-analysis of interventional studies.
    PLoS One. 2022;17:e0269531.
    PubMed     Abstract available


  27. JEONG W
    Association between dual smoking and dyslipidemia in South Korean adults.
    PLoS One. 2022;17:e0270577.
    PubMed     Abstract available


  28. ELALEM EG, Jelani M, Khedr A, Ahmad A, et al
    Association of cytochromes P450 3A4*22 and 3A5*3 genotypes and polymorphism with response to simvastatin in hypercholesterolemia patients.
    PLoS One. 2022;17:e0260824.
    PubMed     Abstract available


  29. OHYA Y, Matsuo R, Sato N, Irie F, et al
    Causes of ischemic stroke in young adults versus non-young adults: A multicenter hospital-based observational study.
    PLoS One. 2022;17:e0268481.
    PubMed     Abstract available


  30. KHANAL MK, Bhandari P, Dhungana RR, Gurung Y, et al
    Poor glycemic control, cardiovascular disease risk factors and their clustering among patients with type 2 diabetes mellitus: A cross-sectional study from Nepal.
    PLoS One. 2022;17:e0271888.
    PubMed     Abstract available


  31. CHENG HY, Fung E, Choi KC, Zou HJ, et al
    Early risk of acute myocardial infarction following hospitalization for severe influenza infection in the middle-aged population of Hong Kong.
    PLoS One. 2022;17:e0272661.
    PubMed     Abstract available


  32. YU W, Gao C, Zhao X, Li C, et al
    Four-way decomposition of effect of cigarette smoking and body mass index on serum lipid profiles.
    PLoS One. 2022;17:e0270486.
    PubMed     Abstract available


  33. NAZLI SA, Chua YA, Mohd Kasim NA, Ismail Z, et al
    Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort.
    PLoS One. 2022;17:e0273896.
    PubMed     Abstract available


  34. HUNG MC, Chen YY
    Association between retinitis pigmentosa and an increased risk of primary angle closure glaucoma: A population-based cohort study.
    PLoS One. 2022;17:e0274066.
    PubMed     Abstract available


  35. TAVOLINEJAD H, Roshani S, Rezaei N, Ghasemi E, et al
    A machine learning approach to evaluate the state of hypertension care coverage: From 2016 STEPs survey in Iran.
    PLoS One. 2022;17:e0273560.
    PubMed     Abstract available


    January 2021
  36. JAYANAMA K, Srichatrapimuk S, Thammavaranucupt K, Kirdlarp S, et al
    The association between body mass index and severity of Coronavirus Disease 2019 (COVID-19): A cohort study.
    PLoS One. 2021;16:e0247023.
    PubMed     Abstract available


  37. ARAUJO COD, Montenegro RM, Pedroso AP, Fernandes VO, et al
    Altered acylated ghrelin response to food intake in congenital generalized lipodystrophy.
    PLoS One. 2021;16:e0244667.
    PubMed     Abstract available


  38. WONG JC, O'Neill S, Beck BR, Forwood MR, et al
    Comparison of obesity and metabolic syndrome prevalence using fat mass index, body mass index and percentage body fat.
    PLoS One. 2021;16:e0245436.
    PubMed     Abstract available


  39. EUSWAS N, Phonnopparat N, Morasert K, Thakhampaeng P, et al
    National trends in the prevalence of diabetic retinopathy among Thai patients with type 2 diabetes and its associated factors from 2014 to 2018.
    PLoS One. 2021;16:e0245801.
    PubMed     Abstract available


  40. GEBREEGZIABIHER G, Belachew T, Mehari K, Tamiru D, et al
    Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia.
    PLoS One. 2021;16:e0243103.
    PubMed     Abstract available


  41. AJABNOOR GMA, Bahijri S, Alamoudi AA, Al Raddadi R, et al
    The association between hypertension and other cardiovascular risk factors among non-diabetic Saudis adults-A cross sectional study.
    PLoS One. 2021;16:e0246568.
    PubMed     Abstract available


  42. SHIN WY, Kim JH
    Poor diet quality is associated with self-reported knee pain in community-dwelling women aged 50 years and older.
    PLoS One. 2021;16:e0245630.
    PubMed     Abstract available


  43. BLAIS JE, Tong GKY, Pathadka S, Mok M, et al
    Comparative efficacy and safety of statin and fibrate monotherapy: A systematic review and meta-analysis of head-to-head randomized controlled trials.
    PLoS One. 2021;16:e0246480.
    PubMed     Abstract available


  44. LEE CY, Liu KT, Lu HT, Mohd Ali R, et al
    Sex and gender differences in presentation, treatment and outcomes in acute coronary syndrome, a 10 year study from a multi-ethnic Asian population: The Malaysian National Cardiovascular Disease Database-Acute Coronary Syndrome (NCVD-ACS) registry.
    PLoS One. 2021;16:e0246474.
    PubMed     Abstract available


  45. ISHIDA S, Kondo S, Funakoshi S, Satoh A, et al
    White blood cell count and incidence of hypertension in the general Japanese population: ISSA-CKD study.
    PLoS One. 2021;16:e0246304.
    PubMed     Abstract available


  46. DADACHANJI R, Patil A, Joshi B, Mukherjee S, et al
    Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women.
    PLoS One. 2021;16:e0246862.
    PubMed     Abstract available


  47. BEHBEHANI R, Ali A, Al-Moosa A
    Risk factors and visual outcome of Non-Arteritic Ischemic Optic Neuropathy (NAION): Experience of a tertiary center in Kuwait.
    PLoS One. 2021;16:e0247126.
    PubMed     Abstract available


  48. TANNOUS A, Bradford AP, Kuhn K, Fought A, et al
    A randomised trial examining inflammatory signaling in acutely induced hyperinsulinemia and hyperlipidemia in normal weight women-the reprometabolic syndrome.
    PLoS One. 2021;16:e0247638.
    PubMed     Abstract available


  49. EUM MJ, Jung HS
    The interplay of sleep duration, working hours, and obesity in Korean male workers: The 2010-2015 Korea National Health and Nutrition Examination Survey.
    PLoS One. 2021;16:e0247746.
    PubMed     Abstract available


  50. KIM JB, Song WH, Park JS, Youn TJ, et al
    A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
    PLoS One. 2021;16:e0245481.
    PubMed     Abstract available


  51. DE BACKER T, Van Nieuwenhuyse B, De Bacquer D
    Antihypertensive treatment in a general uncontrolled hypertensive population in Belgium and Luxembourg in primary care: Therapeutic inertia and treatment simplification. The SIMPLIFY study.
    PLoS One. 2021;16:e0248471.
    PubMed     Abstract available


  52. TRAN DT, Lekhak N, Gutierrez K, Moonie S, et al
    Risk factors associated with cardiovascular disease among adult Nevadans.
    PLoS One. 2021;16:e0247105.
    PubMed     Abstract available


  53. VIMALESWARAN KS, Bodhini D, Jiang J, Ramya K, et al
    Circulating adiponectin mediates the association between omentin gene polymorphism and cardiometabolic health in Asian Indians.
    PLoS One. 2021;16:e0238555.
    PubMed     Abstract available


  54. HAN KT, Kim S
    Do cholesterol levels and continuity of statin use affect colorectal cancer incidence in older adults under 75 years of age?
    PLoS One. 2021;16:e0250716.
    PubMed     Abstract available


  55. KIM SH, Jeong JB, Kang J, Ahn DW, et al
    Association between sarcopenia level and metabolic syndrome.
    PLoS One. 2021;16:e0248856.
    PubMed     Abstract available


  56. LEE DH, Sheen SH, Lee DG, Jang JW, et al
    Association between ischemic stroke and seropositive rheumatoid arthritis in Korea: A nationwide longitudinal cohort study.
    PLoS One. 2021;16:e0251851.
    PubMed     Abstract available


  57. GURM Z, Seth M, Daher E, Pielsticker E, et al
    Prevalence of coronary risk factors in contemporary practice among patients undergoing their first percutaneous coronary intervention: Implications for primary prevention.
    PLoS One. 2021;16:e0250801.
    PubMed     Abstract available


  58. ALHABIB KF, Al-Rasadi K, Almigbal TH, Batais MA, et al
    Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
    PLoS One. 2021;16:e0251560.
    PubMed     Abstract available


  59. NIGUSSIE S, Birhan N, Amare F, Mengistu G, et al
    Rate of glycemic control and associated factors among type two diabetes mellitus patients in Ethiopia: A cross sectional study.
    PLoS One. 2021;16:e0251506.
    PubMed     Abstract available


  60. KIM SJ, Kwon OD, Lee EJ, Ock SM, et al
    Impact of a family history of cardiovascular disease on prevalence, awareness, treatment, control of dyslipidemia, and healthy behaviors: Findings from the Korea National Health and Nutrition Examination Survey.
    PLoS One. 2021;16:e0254907.
    PubMed     Abstract available


  61. GAO H, Wang H, Shan G, Liu R, et al
    Prevalence of dyslipidemia and associated risk factors among adult residents of Shenmu City, China.
    PLoS One. 2021;16:e0250573.
    PubMed     Abstract available


  62. ALSUWAILEM B, Zamzam A, Syed MH, Greco E, et al
    Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
    PLoS One. 2021;16:e0253792.
    PubMed     Abstract available


  63. HARA K, Kobayashi Y, Tomio J, Ito Y, et al
    Claims-based algorithms for common chronic conditions were efficiently constructed using machine learning methods.
    PLoS One. 2021;16:e0254394.
    PubMed     Abstract available


  64. ACCARDO A, Silveri G, Ajcevic M, Miladinovic A, et al
    Influence of smoking and other cardiovascular risk factors on heart rate circadian rhythm in normotensive and hypertensive subjects.
    PLoS One. 2021;16:e0257660.
    PubMed     Abstract available


  65. WASIELICA-POSLEDNIK J, Hampel U, Ries L, Faysal R, et al
    Prevalence of corneal arcus and associated factors in a German population-Results from the Gutenberg Health Study.
    PLoS One. 2021;16:e0255893.
    PubMed     Abstract available


  66. NIEDZIELSKI M, Broncel M, Gorzelak-Pabis P, Wozniak E, et al
    A comparison of the effects of monotherapy with rosuvastatin, atorvastatin or ezetimibe versus combination treatment with rosuvastatin-ezetimibe and atorvastatin-ezetimibe on the integrity of vascular endothelial cells damaged by oxidized cholesterol.
    PLoS One. 2021;16:e0256996.
    PubMed     Abstract available


  67. HATMAL MM, Alshaer W, Mahmoud IS, Al-Hatamleh MAI, et al
    Investigating the association of CD36 gene polymorphisms (rs1761667 and rs1527483) with T2DM and dyslipidemia: Statistical analysis, machine learning based prediction, and meta-analysis.
    PLoS One. 2021;16:e0257857.
    PubMed     Abstract available


  68. SABRY M, Mostafa S, Kamar S, Rashed L, et al
    The cross-talk between matrix metalloproteinase-9, RANKL/OPG system and cardiovascular risk factors in ovariectomized rat model of postmenopausal osteoporosis.
    PLoS One. 2021;16:e0258254.
    PubMed     Abstract available


  69. AKINMOLAYEMI O, Saldanha S, Joshi PH, Deodhar S, et al
    Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study).
    PLoS One. 2021;16:e0257574.
    PubMed     Abstract available


  70. LIU J, Chen Y, Jin C, Chen D, et al
    Analysis of prevalence and influencing factors of stroke in elderly hypertensive patients: Based on the screening plan for the high-risk population of stroke in Jiading District, Shanghai.
    PLoS One. 2021;16:e0255279.
    PubMed     Abstract available


  71. FERRIERES J, Banks V, Pillas D, Giorgianni F, et al
    Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study.
    PLoS One. 2021;16:e0255345.
    PubMed     Abstract available


  72. FERRARA P, Di Laura D, Cortesi PA, Mantovani LG, et al
    The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies.
    PLoS One. 2021;16:e0254631.
    PubMed     Abstract available


  73. LEE KI, In SM, Kim JY, Hong JY, et al
    Association of nasal septal deviation with the incidence of anxiety, depression, and migraine: A national population-based study.
    PLoS One. 2021;16:e0259468.
    PubMed     Abstract available


  74. ABATE TW, Zeleke B, Genanew A, Abate BW, et al
    The burden of stroke and modifiable risk factors in Ethiopia: A systemic review and meta-analysis.
    PLoS One. 2021;16:e0259244.
    PubMed     Abstract available


  75. URASHIMA K, Miramontes A, Garcia LA, Coletta DK, et al
    Potential evidence for epigenetic biomarkers of metabolic syndrome in human whole blood in Latinos.
    PLoS One. 2021;16:e0259449.
    PubMed     Abstract available


  76. GEBREMEDHIN MH, Lake EA, Gebrekirstos LG
    Heavy khat (Catha edulis) chewing and dyslipidemia as modifiable hypertensive risk factors among patients in Southwest, Ethiopia: Unmatched case-control study.
    PLoS One. 2021;16:e0259078.
    PubMed     Abstract available


  77. SQUIER K, Scott A, Hunt MA, Brunham LR, et al
    The effects of cholesterol accumulation on Achilles tendon biomechanics: A cross-sectional study.
    PLoS One. 2021;16:e0257269.
    PubMed     Abstract available


  78. WATANABE H, Takenouchi K, Kimura M
    MIHARI project, a preceding study of MID-NET, adverse event detection database of Ministry Health of Japan-Validation study of the signal detection of adverse events of drugs using export data from EMR and medical claim data.
    PLoS One. 2021;16:e0255863.
    PubMed     Abstract available


  79. KIM SH, Kang HW, Jeong JB, Lee DS, et al
    Association of obesity, visceral adiposity, and sarcopenia with an increased risk of metabolic syndrome: A retrospective study.
    PLoS One. 2021;16:e0256083.
    PubMed     Abstract available


  80. LIM CY, Ho JS, Huang Z, Gao F, et al
    Public perceptions and knowledge of cholesterol management in a multi-ethnic Asian population: A population-based survey.
    PLoS One. 2021;16:e0256218.
    PubMed     Abstract available


  81. WU Y, Peng T, Chen Y, Huang L, et al
    Acupuncture for glucose and lipid metabolic disorders of polycystic ovarian syndrome: A systematic review protocol.
    PLoS One. 2021;16:e0255732.
    PubMed     Abstract available


  82. GUO X, Zhao B, Chen T, Hao B, et al
    Multimorbidity in the elderly in China based on the China Health and Retirement Longitudinal Study.
    PLoS One. 2021;16:e0255908.
    PubMed     Abstract available


  83. ALFAIFI AA, Lai L, Althemery AU
    Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework.
    PLoS One. 2021;16:e0255729.
    PubMed     Abstract available


  84. DESHYCKA R, Sudaryo V, Huang NJ, Xie Y, et al
    Engineered red blood cells carrying PCSK9 inhibitors persistently lower LDL and prevent obesity.
    PLoS One. 2021;16:e0259353.
    PubMed     Abstract available


  85. PULIPATI VP, Amblee A, Yap SET, Shaka H, et al
    Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion.
    PLoS One. 2021;16:e0260495.
    PubMed     Abstract available


  86. LEE S, Yang S, Chang MJ
    Antihypertensive effects of rosuvastatin in patients with hypertension and dyslipidemia: A systemic review and meta-analysis of randomized studies.
    PLoS One. 2021;16:e0260391.
    PubMed     Abstract available


  87. LEE Y, Shin J, Kim Y, Kim DS, et al
    Consumption of single products versus fixed-dose combination medicines for hypertension and hyperlipidemia during 2015-2019 in South Korea.
    PLoS One. 2021;16:e0259467.
    PubMed     Abstract available


  88. ANDERSON K, Bavishi C, Kolte D, Gohh R, et al
    Relation of abnormal cardiac stress testing with outcomes in patients undergoing renal transplantation.
    PLoS One. 2021;16:e0260718.
    PubMed     Abstract available


  89. JOO YH, Lee HJ, Park JO, Seo YJ, et al
    The risk of laryngitis with herpes zoster infection: A nested case-control study using data from the Korean National Sample Cohort.
    PLoS One. 2021;16:e0261366.
    PubMed     Abstract available


    January 2020
  90. NAKAMORI M, Imamura E, Fukuta M, Tachiyama K, et al
    Tongue thickness measured by ultrasonography is associated with tongue pressure in the Japanese elderly.
    PLoS One. 2020;15:e0230224.
    PubMed     Abstract available


  91. KHALIL MI, Salwa M, Sultana S, Al Mamun MA, et al
    Role of serum uric acid in ischemic stroke: A case-control study in Bangladesh.
    PLoS One. 2020;15:e0236747.
    PubMed     Abstract available


  92. LEE HJ, Kim CO, Lee DC
    Association between daily sunlight exposure duration and diabetic retinopathy in Korean adults with diabetes: A nationwide population-based cross-sectional study.
    PLoS One. 2020;15:e0237149.
    PubMed     Abstract available


  93. KAUR S U, Oyeyemi BF, Shet A, Gopalan BP, et al
    Plasma metabolomic study in perinatally HIV-infected children using 1H NMR spectroscopy reveals perturbed metabolites that sustain during therapy.
    PLoS One. 2020;15:e0238316.
    PubMed     Abstract available


  94. LEE JH, Song DY, Jun SH, Song SH, et al
    High prevalence of increased sitosterol levels in hypercholesterolemic children suggest underestimation of sitosterolemia incidence.
    PLoS One. 2020;15:e0238079.
    PubMed     Abstract available


  95. KAPOOR N, Lotfaliany M, Sathish T, Thankappan KR, et al
    Prevalence of normal weight obesity and its associated cardio-metabolic risk factors - Results from the baseline data of the Kerala Diabetes Prevention Program (KDPP).
    PLoS One. 2020;15:e0237974.
    PubMed     Abstract available


  96. LIU KL, Tsai WC, Tu HP, Lee CH, et al
    Statin use and the risk of chronic kidney disease in patients with psoriasis: A nationwide cohort study in Taiwan.
    PLoS One. 2020;15:e0237816.
    PubMed     Abstract available


  97. KIM T, Choi H, Kang J, Kim J, et al
    Association between electronic cigarette use and metabolic syndrome in the Korean general population: A nationwide population-based study.
    PLoS One. 2020;15:e0237983.
    PubMed     Abstract available


  98. KYPRIANIDOU M, Panagiotakos D, Faka A, Kambanaros M, et al
    Prevalence of multimorbidity in the Cypriot population; A cross-sectional study (2018-2019).
    PLoS One. 2020;15:e0239835.
    PubMed     Abstract available


  99. IZCOVICH A, Ragusa MA, Tortosa F, Lavena Marzio MA, et al
    Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review.
    PLoS One. 2020;15:e0241955.
    PubMed     Abstract available


  100. THOMAS R, Spence MT, Roy R, Beller E, et al
    A randomised on-line survey exploring how health condition labels affect behavioural intentions.
    PLoS One. 2020;15:e0240985.
    PubMed     Abstract available


  101. MIETUS-SNYDER M, Narayanan N, Krauss RM, Laine-Graves K, et al
    Randomized nutrient bar supplementation improves exercise-associated changes in plasma metabolome in adolescents and adult family members at cardiometabolic risk.
    PLoS One. 2020;15:e0240437.
    PubMed     Abstract available


  102. VERONEZE R, Cruz Tfaile Corbi S, Roque da Silva B, de S Rocha C, et al
    Using association rule mining to jointly detect clinical features and differentially expressed genes related to chronic inflammatory diseases.
    PLoS One. 2020;15:e0240269.
    PubMed     Abstract available


  103. SINGH G, Hussain Y, Xu Z, Sholle E, et al
    Comparing a novel machine learning method to the Friedewald formula and Martin-Hopkins equation for low-density lipoprotein estimation.
    PLoS One. 2020;15:e0239934.
    PubMed     Abstract available


  104. BORKOWSKI K, Newman JW, Aghaeepour N, Mayo JA, et al
    Mid-gestation serum lipidomic profile associations with spontaneous preterm birth are influenced by body mass index.
    PLoS One. 2020;15:e0239115.
    PubMed     Abstract available


  105. CHO JH, Lim YC, Han KD, Lee JY, et al
    The incidence of malignant brain tumors is increased in patients with obstructive sleep apnea: A national health insurance survey.
    PLoS One. 2020;15:e0241598.
    PubMed     Abstract available


  106. MAIGA Y, Diallo S, Konipo FDN, Sangho O, et al
    Diabetic polyneuropathy with/out neuropathic pain in Mali: A cross-sectional study in two reference diabetes treatment centers in Bamako (Mali), Western Africa.
    PLoS One. 2020;15:e0241387.
    PubMed     Abstract available


  107. BOVE KB, Nilsson M, Pedersen LR, Mikkelsen N, et al
    Comprehensive treatment of microvascular angina in overweight women - a randomized controlled pilot trial.
    PLoS One. 2020;15:e0240722.
    PubMed     Abstract available


  108. ZOU Y, Sheng G, Yu M, Xie G, et al
    The association between triglycerides and ectopic fat obesity: An inverted U-shaped curve.
    PLoS One. 2020;15:e0243068.
    PubMed     Abstract available


  109. ANANTHAKUMAR A, Liu Y, Fernandez CE, Truskey GA, et al
    Modeling statin myopathy in a human skeletal muscle microphysiological system.
    PLoS One. 2020;15:e0242422.
    PubMed     Abstract available


  110. HARBER MP, Metz M, Peterman JE, Whaley MH, et al
    Trends in cardiorespiratory fitness among apparently healthy adults from the Ball State Adult Fitness Longitudinal Lifestyle STudy (BALL ST) cohort from 1970-2019.
    PLoS One. 2020;15:e0242995.
    PubMed     Abstract available


  111. JONES LK, Sturm AC, Seaton TL, Gregor C, et al
    Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.
    PLoS One. 2020;15:e0244193.
    PubMed     Abstract available


  112. SEMMLER G, Bachmayer S, Wernly S, Wernly B, et al
    Nut consumption and the prevalence and severity of non-alcoholic fatty liver disease.
    PLoS One. 2020;15:e0244514.
    PubMed     Abstract available


  113. PAWLOS A, Broncel M, Wlazlowska E, Jablonowska E, et al
    Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations.
    PLoS One. 2020;15:e0244675.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Dyslipidemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: